Sep 23, 2026 04:45AM
Sep 14, 2026 07:46AM
Aug 18, 2026 04:15AM
Jun 16, 2026 05:17AM
Apr 27, 2026 01:58AM
Apr 15, 2026 08:08AM
Apr 8, 2026 04:35PM TuHURA Biosciences enters $50 million at-the-market offering agreement
Apr 7, 2026 07:47AM
Mar 24, 2026 10:30AM
Mar 23, 2026 07:45AM
Feb 17, 2026 07:46AM
Feb 2, 2026 07:45AM
Dec 15, 2025 07:51AM
Dec 11, 2025 07:30AM TuHURA Biosciences raises $15.6 million in equity financing
Dec 8, 2025 07:50AM
Nov 14, 2025 07:50AM
Nov 3, 2025 09:02AM
Aug 22, 2025 06:58AM
Jul 1, 2025 08:50AM
Jun 30, 2025 08:51AM
Jun 30, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on TuHURA Biosciences (HURA)
Jun 24, 2025 08:04AM
Jun 23, 2025 05:02PM
Jun 23, 2025 09:16AM
Jun 9, 2025 10:12AM
Jun 9, 2025 08:01AM
Jun 3, 2025 10:00AM
May 5, 2025 08:06AM TuHURA Biosciences (HURA) Initiates Phase 1b/2a Study of IFx-Hu2.0 as an Adjunctive Therapy to Keytruda in First Line Treatment for MCCUP
Apr 28, 2025 08:04AM
Apr 7, 2025 08:25AM
Apr 3, 2025 06:45AM
Mar 11, 2025 08:05AM
Mar 10, 2025 09:00AM
Feb 19, 2025 09:00AM
Dec 19, 2024 05:48AM Rodman & Renshaw Starts TuHURA Biosciences (HURA) at Buy
Dec 13, 2024 01:21PM
Dec 12, 2024 08:46AM
Dec 12, 2024 08:45AM
Nov 25, 2024 08:39AM
Nov 25, 2024 08:35AM
Oct 23, 2024 08:30AM
Oct 22, 2024 09:00AM TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event
Oct 17, 2024 04:38PM
Oct 17, 2024 04:35PM

455,598 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All